Dr. Guy Goodwin is the Chief Medical Officer at COMPASS Pathways and an Emeritus Professor of Psychiatry at the University of Oxford, UK. His research focuses on the neurobiology and treatment of mood disorders, such as bipolar depression, with a focus on the commercial development of COMP360 psilocybin.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)